VivoSeq
Other

Anhedonia

0

Pipeline Programs↗

3

Active Trials↗

2

Companies Involved↗

Anhedonia is an early-stage landscape with 0 programs across 2 companies. The most active players are Johnson & Johnson, Magnetic Tides.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Johnson & Johnson logo

Johnson & Johnson

0 programs

PreclinicalM

Magnetic Tides

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Completed4 · 57%
Not yet recruiting2 · 29%
Recruiting1 · 14%

Clinical Trials

Trial Activity

7 trials

Dopaminergic Therapy for Anhedonia - 2
Recruiting·EEmory University·Phase 4·NCT06075771·70 enrolled
Clinical and Neurocomputational Effects of Behavioral Activation in Veterans With Impaired Social Functioning
Not yet recruiting·VVA Office of Research and Development·Phase 2·NCT07697001·136 enrolled
Efficacy of kTMP, a Novel Non-invasive Brain Stimulation Method, for the Treatment of Anhedonia
Not yet recruiting·—·Preclinical·NCT07032428·104 enrolled
DTA (Dopaminergic Therapy for Anhedonia) Study
Completed·EEmory University·Phase 4·NCT04723147·19 enrolled
Adjunctive Game Intervention for Anhedonia in MDD Patients
Completed·—·N/A·NCT04977232·50 enrolled
A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
Completed·Johnson & Johnson logoJohnson & Johnson·Phase 3·NCT05550532·444 enrolled
Reward Responsiveness as a Prevention Target in Youth At Risk for Anhedonia
Completed·VVanderbilt University·Preclinical·NCT05988138·73 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)